???pagination.result.count???
???pagination.result.page???
1
A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy. , Muona M., Nat Genet. January 1, 2015; 47 (1): 39-46.
Frequency of KCNC3 DNA variants as causes of spinocerebellar ataxia 13 ( SCA13). , Figueroa KP., PLoS One. March 29, 2011; 6 (3): e17811.
Binding site of a novel Kv1.5 blocker: a "foot in the door" against atrial fibrillation. , Decher N., Mol Pharmacol. October 1, 2006; 70 (4): 1204-11.
Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current. , Lagrutta A., J Pharmacol Exp Ther. June 1, 2006; 317 (3): 1054-63.
Deranged Kv channel regulation in fibroblasts from mice lacking the serum and glucocorticoid inducible kinase SGK1. , Shumilina E., J Cell Physiol. July 1, 2005; 204 (1): 87-98.
Role of transmembrane segment S5 on gating of voltage-dependent K+ channels. , Shieh CC., J Gen Physiol. June 1, 1997; 109 (6): 767-78.
Full-length and truncated Kv1.3 K+ channels are modulated by 5-HT1c receptor activation and independently by PKC. , Aiyar J., Am J Physiol. December 1, 1993; 265 (6 Pt 1): C1571-8.